| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium ruminatum co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium ruminatum co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pitavastatin calcium |
Click to Show/Hide the Detail |
| Drug ID |
DR1306
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Collinsella aerofaciens co-metabolize the drug Pitavastatin calcium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [7], [8] |
| Bacteria: Bacteroidetes |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides cellulosilyticus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides ovatus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides stercoris co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides stercoris co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Telmisartan |
Click to Show/Hide the Detail |
| Drug ID |
DR1545
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides johnsonii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides johnsonii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides merdae co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides merdae co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Firmicutes |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [13] |
| Bacillus pumilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Gemfibrozil |
Click to Show/Hide the Detail |
| Drug ID |
DR0766
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacillus pumilus co-metabolize the drug Gemfibrozil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [15] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Anastrozole |
Click to Show/Hide the Detail |
| Drug ID |
DR0113
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Blautia hansenii co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Blautia hansenii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Blautia hansenii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Anastrozole |
Click to Show/Hide the Detail |
| Drug ID |
DR0113
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium botulinum co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium botulinum co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium sporogenes co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
| Bacteria: Fusobacteria |
| Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Proteobacteria |
| Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ibuprofen |
Click to Show/Hide the Detail |
| Drug ID |
DR0844
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [17] |
|
|
|
|
|
|